Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.7645
+0.0129 (1.71%)
Dec 15, 2025, 2:40 PM EST - Market open

Purple Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
71122276867
Upgrade
Market Cap Growth
44.45%-48.88%-19.26%-60.77%1.95%364.71%
Upgrade
Enterprise Value
-355-622-0
Upgrade
Last Close Price
0.754.6915.6027.6077.8076.20
Upgrade
PB Ratio
0.230.340.630.571.050.84
Upgrade
P/TBV Ratio
1.522.213.521.021.541.14
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.01
Upgrade
Quick Ratio
1.732.141.594.5511.1118.82
Upgrade
Current Ratio
1.782.231.634.7111.4119.14
Upgrade
Return on Equity (ROE)
-10.48%-21.66%-49.09%-38.79%-24.61%-63.35%
Upgrade
Return on Assets (ROA)
-8.48%-16.60%-28.14%-22.63%-14.55%-16.74%
Upgrade
Return on Capital (ROIC)
-10.02%-19.93%-33.84%-24.90%-15.29%-17.98%
Upgrade
Return on Capital Employed (ROCE)
-15.20%-32.70%-64.40%-47.50%-27.20%-16.40%
Upgrade
Earnings Yield
-43.36%-65.38%-91.76%-80.75%-26.88%-41.74%
Upgrade
FCF Yield
-88.07%-129.73%-91.98%-62.47%-22.47%-18.26%
Upgrade
Buyback Yield / Dilution
-106.88%-48.17%-22.41%-2.92%-52.76%-493.78%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q